Rise in demand for clean-label & allergen-free plant-based protein products are the major driving forces of the global Potato Protein market. </ ...

Request Sample PDF Of This Report: The global dairy protein industry size generated ... and bodybuilders as it offers overall body growth and muscle building along with rise in demand for sports ...

Several brands are taking the precautionary step of recalling several spice products that contain mustard. They may contain peanuts which are not mentioned on the label. This means the products are a ...

The Food and Drug Administration (FDA) has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia (ALL), as part of a ...

A dietitian teaches us how to identify hidden sugars, artificial sweeteners, and unhealthy fats in these unhealthy protein ...

The Food and Drug Administration (FDA) has granted accelerated approval to Scemblix ® (asciminib) for the treatment of adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid ...

it’s essential to note that while the label does not mention these ingredients explicitly, individuals with severe allergies or sensitivities should consult with a healthcare professional or contact ...

Secret Double Octopus, the market leader in workforce passwordless authentication, today announced the successful raising of ...

The expanded indication in Ph+ CML-CP increases the population eligible for Scemblix by approximately four times, including newly diagnosed and previously treated adults. Newly diagnosed patients will ...

According to a study by the University of the Basque Country (UPV/EHU), the Internet is the go-to source for most people with celiac disease when tackling their dietary queries.

The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a ...

Ad hoc announcement pursuant to Art. 53 LR Scemblix, a new first-line option for adults with CML, is first to show superior efficacy and favorable safety and tolerability profile in a Phase III trial ...